MSCI USA IMI Biotech Advance Index

The MSCI USA IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation in the US market, that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Get in touch
Document downloads
Index code
753365
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.85
P/E
73.05
P/E Fwd
39.97
P/BV
5.25
Number of constituents
83
Index Market Cap
$2.03 T
Largest constituent Market Cap
$205.49 B
Smallest constituent Market Cap
$1.64 B
Average constituent Market Cap
$24.53 B
Median constituent Market Cap
$7.53 B
Does this benchmark pursue ESG objectives?
No
Data as of Aug. 29, 2025 

Want to learn more about MSCI indexes?
Get in touch.

Contact us